Back to Research Blog
Tissue Repair

TB-500 and Thymosin Beta-4: Actin Sequestration and Tissue Healing Mechanisms

TB-500 is a synthetic peptide fragment corresponding to the active region of Thymosin Beta-4 (Tβ4), a ubiquitous protein with a central role in actin dynamics, cell migration, and tissue repair.

Purely Peptides Research TeamMarch 12, 2025Updated: Apr 1, 20258 min read
TB-500thymosin beta-4actinwound healingcardioprotectionILK
Research Use Only. All compounds discussed are sold exclusively for laboratory and in vitro research purposes. Nothing on this page constitutes medical advice or recommendation for human use.

Thymosin Beta-4 (Tβ4) is a 43-amino acid protein found in virtually all mammalian cells. TB-500 is a synthetic analog corresponding to the actin-binding domain of Tβ4 (residues 17–23: LKKTETQ), preserving the key functional activity of the parent protein in a smaller molecule.

G-Actin Sequestration

Tβ4's primary function is sequestration of G-actin (monomeric actin) in a 1:1 complex, modulating the G:F actin equilibrium. By buffering available G-actin, TB-500 controls the rate and direction of actin polymerization — translating to directed lamellipodia formation and accelerated cell migration toward wound sites. Keratinocytes, fibroblasts, and endothelial cells treated with Tβ4 show significantly increased migration in scratch assay models.

Integrin-Linked Kinase (ILK) Upregulation

TB-500 upregulates ILK, a serine/threonine kinase at focal adhesions that activates Akt/PKB and β-catenin survival and proliferation pathways. In myocardial infarction models, Tβ4 pretreatment activates ILK-Akt signaling to promote cardiomyocyte survival and reduce infarct size.

Cardiovascular Research

Studies from Smart et al. (MRC, UK) demonstrated Tβ4 reactivates embryonic cardiac progenitors in the adult epicardium. In mouse MI models, Tβ4 significantly improved cardiac function at 4 weeks, reduced fibrosis, and promoted new vessel formation in the infarct zone.

Wound Healing

In corneal wound healing — one of the few human-adjacent datasets for this compound class — Tβ4-containing eye drops significantly accelerated epithelial healing versus vehicle controls in a Phase II clinical trial.

TB-500 is a component of our Glow Blend:

Glow Blend — View Product Page →

References

  1. Goldstein AL, Hannappel E, Kleinman HK. (2005). Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med, 11(9), 421–429.
  2. Smart N, et al. (2007). Thymosin β4 induces adult epicardial progenitor mobilization. Nature, 445(7124), 177–182.
  3. Sosne G, et al. (2010). Thymosin beta 4 and corneal wound healing. Ann NY Acad Sci, 1194, 190–198.
  4. Bock-Marquette I, et al. (2004). Thymosin β4 activates integrin-linked kinase and promotes cardiac repair. Nature, 432(7016), 466–472.

Research Compounds Discussed